site:www.urotoday.com - Search Videos

Lutetium PSMA Therapy in mCRPC: Real-World Evidence from PRECISION Data Platform - Oliver Sartor

Lutetium PSMA Therapy in mCRPC: Real-World Evidence from PRECIS…

Real-World Analysis of Genetic Testing Rates and Barriers in Metastatic Prostate Cancer - Pedro Barata

Real-World Analysis of Genetic Testing Rates and Barriers in Meta…

Feasibility of Using an RNA-Seq Biomarker to Assign Therapy in the OPTIC RCC Trial - Pedro Barata

Feasibility of Using an RNA-Seq Biomarker to Assign Therapy in th…

Phase II NESCIO Trial of Neoadjuvant Immunotherapy in Renal Cell Carcinoma - Femke Burgers

Phase II NESCIO Trial of Neoadjuvant Immunotherapy in R…

Advances in Targeting Cell Surface Proteins in Prostate Cancer - Andrew Hahn

Advances in Targeting Cell Surface Proteins in Prostate Cancer - Andr…

Real-World Safety Profiles of First-Line Therapies for Advanced Urothelial Carcinoma - Amanda Nizam

Real-World Safety Profiles of First-Line Therapies for Advanced Urot…

A Real-World Study of mHSPC Patients: Comparative Survival with Apalutamide and Enzalutamide - Neal Shore

A Real-World Study of mHSPC Patients: Comparative Survival wit…

Advancing the Management of Indeterminate Renal Masses: The …

GTB-5550: A Tri-specific NK Cell Engager Designed to Target B7-H…

PSA Thresholds in mHSPC: What VA Data Reveals About Optimal T…

Phase Ib/II Trial Combines Ciforadenant with Ipilimumab and …

Investigational Therapies Target STEAP1 and DLL3 in Advanced Pr…

EV-302: Enfortumab Vedotin + Pembrolizumab Outperforms Che…

Real-World Analysis of Nadofaragene Firadenovec and Be…

LUNAR Trial: Neoadjuvant Lutetium-PSMA Plus SBRT Evaluated in Oli…

COTRIMS Trial Shows High Cure Rates with RPLND in Stage IIA/B S…

TRIPLE-SWITCH Trial Tests Docetaxel Addition for mHSPC Pat…

Targeting SPP1+ Macrophages and the Adenosine Pathway to Boost …

Final Analysis of Phase 3 POTOMAC Study in High-Risk NMIBC - Maria …

History, Outcomes, and Guideline-Based Options for Sling Procedur…

NIDDK-Funded Urology Research and Future Directions - Margot Da…

Health-Related Quality of Life Outcomes from the NIAGARA Tria…

First-Line Combination Treatment with PARP and Androgen Recepto…

CISTO Trial Examines One-Year Survival Between Bladder Remova…

Surgical Treatment Options for Stable Peyronie's Disease - Laure…

Real-World Study of Apalutamide and Enzalutamide in Metastatic Ho…

Analysis of MRI Use in the Diagnostic Pathway for Bladder C…

See more videos